Research has found that, in diabetic models, EGCG indirectly inhibits the stability of TLR4 mRNA by promoting Fat Mass and Obesity-Associated Protein degradation, thereby reducing TLR4 protein expression [39]. Here, TLR4 is linked to obesity due to melanocortin 4 receptor deficiency.